Interrupting methotrexate to improve immunity after COVID-19 booster vaccination: is it really worth it?

Jorda, Anselm; Zeitlinger, Markus

Jorda, Anselm; Zeitlinger, Markus.

Jorda A; Department of Clinical Pharmacology, Medical University of Vienna, Vienna 1090, Austria.
Zeitlinger M; Department of Clinical Pharmacology, Medical University of Vienna, Vienna 1090, Austria. Electronic address: markus.zeitlinger@meduniwien.ac.at.

Lancet Respir Med ; 10(9): e80, 2022 09.

Article in English | MEDLINE | ID: covidwho-2004670

Subject(s)

COVID-19; Methotrexate; COVID-19/prevention & control; Enzyme-Linked Immunosorbent Assay; Humans; Methotrexate/therapeutic use; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Methotrexate / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Lancet Respir Med Year: 2022 Document Type: Article Affiliation country: S2213-2600(22)00271-5

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google